Sevoflurane, a sigh of relief in COVID-19?

Szczegóły

Tytuł:: Sevoflurane, a sigh of relief in COVID-19?
Autorzy:: Nieuwenhuijs-Moeke GJ; Department of Anaesthesiology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands. Electronic address: .
Jainandunsing JS; Department of Anaesthesiology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
Struys MMRF; Department of Anaesthesiology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands; Department of Basic and Applied Medical Sciences, Ghent University, Gent, Belgium.
Źródło:: British journal of anaesthesia [Br J Anaesth] 2020 Aug; Vol. 125 (2), pp. 118-121. Date of Electronic Publication: 2020 May 01.
Typ publikacji:: Editorial; Research Support, Non-U.S. Gov't
Język:: English
Imprint Name(s):: Publication: 2018- : [London] : Elsevier
Original Publication: London, Eng. [etc.]
MeSH Terms:: Anesthetics, Inhalation*/administration & dosage
Sevoflurane*/administration & dosage
Conscious Sedation/*methods
Coronavirus Infections/*therapy
Pneumonia, Viral/*therapy
Respiration, Artificial/*methods
COVID-19 ; Coronavirus Infections/complications ; Humans ; Pandemics ; Pneumonia, Viral/complications ; Respiration, Artificial/adverse effects ; Respiratory Distress Syndrome
References:: Anesthesiology. 1995 Sep;83(3):449-58. (PMID: 7661345)
Springerplus. 2016 Apr 06;5:420. (PMID: 27099825)
JAMA. 1973 Sep 24;225(13):1611-6. (PMID: 4740737)
Intensive Care Med. 2011 Jun;37(6):933-41. (PMID: 21445642)
Br J Anaesth. 2019 May;122(5):e73-e75. (PMID: 30916031)
Anesthesiology. 2013 Oct;119(4):901-6. (PMID: 23867232)
J Crit Care. 2009 Dec;24(4):535-44. (PMID: 19327951)
Antimicrob Agents Chemother. 1984 Jun;25(6):719-24. (PMID: 6742816)
Anesthesiology. 2016 Aug;125(2):399-411. (PMID: 27286478)
FASEB J. 2019 Nov;33(11):12668-12679. (PMID: 31513427)
Antimicrob Agents Chemother. 1981 Sep;20(3):298-306. (PMID: 7305320)
Antimicrob Agents Chemother. 1980 May;17(5):890-6. (PMID: 6156646)
Anesthesiology. 2015 Sep;123(3):590-602. (PMID: 26120770)
Anesth Analg. 2009 Jun;108(6):1848-54. (PMID: 19448211)
Eur J Anaesthesiol. 2013 Aug;30(8):455-63. (PMID: 23545542)
Anaesthesia. 1974 May;29(3):280-9. (PMID: 4600937)
Ger Med Sci. 2015 Nov 12;13:Doc19. (PMID: 26609286)
Eur J Anaesthesiol. 2017 Nov;34(11):764-775. (PMID: 28759530)
A A Pract. 2019 Mar 1;12(5):155-159. (PMID: 30130280)
Minerva Anestesiol. 2017 Jul;83(7):737-748. (PMID: 28275227)
Br J Anaesth. 2010 Dec;105(6):760-6. (PMID: 20935004)
Lancet. 2020 Mar 28;395(10229):1033-1034. (PMID: 32192578)
Am J Respir Crit Care Med. 2017 Mar 15;195(6):792-800. (PMID: 27611637)
Eur J Anaesthesiol. 2016 Jan;33(1):6-13. (PMID: 25793760)
Contributed Indexing:: Keywords: ARDS; COVID-19; ICU; sedation; sepsis; sevoflurane; volatile anaesthetic
Substance Nomenclature:: 0 (Anesthetics, Inhalation)
38LVP0K73A (Sevoflurane)
Entry Date(s):: Date Created: 20200518 Date Completed: 20200806 Latest Revision: 20210110
Update Code:: 20240105
PubMed Central ID:: PMC7252148
DOI:: 10.1016/j.bja.2020.04.076
PMID:: 32416995
: Raport

Informacja